4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001103
CEO and CFO bought 3,400 shares at $12.95 ($44,030)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-01-03 | Purchase | +3,400 | $12.95 | $44,030 | 5,547,102 | D: show line 1 in the form |
| Open-market purchases · 3,400 sh · avg $12.95 · $44,030 | |||||||
Loading xslF345X05/ownership.xml…